Edwards Lifesciences (EW) Inventory (2009 - 2026)

Edwards Lifesciences' Inventory history runs 18 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

• On a quarterly basis, Inventory changed 0.46% year-over-year to $1.1 billion in Q1 2026; TTM through Mar 2026 was $1.1 billion, a 0.46% change from a year earlier, with the FY2025 full-year figure at $1.1 billion, up 3.63% from the prior year.
• Inventory declined to $1.1 billion in Q1 2026 per EW's latest filing, from $1.1 billion in the prior quarter.
• Across five years, Inventory topped out at $1.2 billion in Q1 2024 and bottomed at $730.6 million in Q1 2022.
• The 5-year median for Inventory is $1.0 billion (2023), against an average of $999.9 million.
• Across the five-year window, Inventory surged 36.24% in 2023 and slipped 7.74% in 2025, its largest moves.
• Year by year, Inventory stood at $875.5 million in 2022, then gained by 3.2% to $903.5 million in 2023, then gained by 20.28% to $1.1 billion in 2024, then advanced by 3.63% to $1.1 billion in 2025, then declined by 0.64% to $1.1 billion in 2026.
• Per Business Quant, the three latest EW Inventory figures stand at $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.1 billion (Q3 2025).